Status and phase
Conditions
Treatments
About
The purpose of this study is to determine whether docetaxel, cisplatin, and capecitabine (DCX) are effective as the neoadjuvant chemotherapy before esophagectomy in patients with loco-regional esophageal squamous cell carcinoma (ESCC).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
80 participants in 1 patient group
Loading...
Central trial contact
Jiayu Ling, MD; Yanhong Deng, MD PHD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal